We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESIO
676
DELISTED
Electro Scientific Industries
ESIO
| $621K | 0.01% |
110,161
-5,300
| -5% | -$31K |
|
|
BELFB
677
Bel Fuse Inc Class B
BELFB
$3.88B
| $618K | 0.01% |
25,616
-300
| -1% | -$6.39K |
|
|
MNDT
678
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $612K | 0.01% |
+41,540
| New | +$638K |
|
|
PSIX
679
Power Solutions International
PSIX
$691M
| $608K | 0.01% |
59,280
+13,850
| +30% | +$199K |
|
680
Markel Group
MKL
$25B
| $606K | 0.01% |
652
-15,663
| -96% | -$14.6M |
|
|
ACAT
681
DELISTED
Arctic Cat Inc
ACAT
| $606K | 0.01% |
39,140
| – | – |
|
682
Motorola Solutions
MSI
$69.4B
| $602K | 0.01% |
7,889
-7,059
| -47% | -$516K |
|
|
PBPB
683
DELISTED
Potbelly
PBPB
| $599K | 0.01% |
48,200
+5,000
| +12% | +$64.7K |
|
|
OMN
684
DELISTED
OMNOVA Solutions Inc.
OMN
| $599K | 0.01% |
71,000
+27,700
| +64% | +$258K |
|
|
CPLA
685
DELISTED
Capella Education Company
CPLA
| $599K | 0.01% |
10,320
| – | – |
|
|
ACC
686
DELISTED
American Campus Communities, Inc.
ACC
| $593K | 0.01% |
11,650
+170
| +1% | +$8.72K |
|
|
BGG
687
DELISTED
Briggs & Stratton Corp.
BGG
| $589K | 0.01% |
31,600
| – | – |
|
688
Citi Trends
CTRN
$524M
| $588K | 0.01% |
29,490
| – | – |
|
689
Enviri
NVRI
$621M
| $588K | 0.01% |
59,191
-5,900
| -9% | -$56.2K |
|
|
MXWL
690
DELISTED
Maxwell Technologies Inc
MXWL
| $584K | 0.01% |
113,148
+17,500
| +18% | +$90.8K |
|
691
Mondelez International
MDLZ
$77.7B
| $576K | 0.01% |
13,130
+2,380
| +22% | +$104K |
|
|
BRSS
692
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $575K | 0.01% |
19,920
-9,574
| -32% | -$272K |
|
693
AMERISAFE
AMSF
$569M
| $570K | 0.01% |
9,700
-1,890
| -16% | -$112K |
|
694
Workiva
WK
$2.94B
| $567K | 0.01% |
31,259
| – | – |
|
695
Lantheus
LNTH
$6.82B
| $566K | 0.01% |
68,330
-11,402
| -14% | -$75.5K |
|
|
IMGN
696
DELISTED
Immunogen Inc
IMGN
| $561K | 0.01% |
209,500
-126,100
| -38% | -$367K |
|
|
RPRX
697
DELISTED
Repros Therapeutics Inc.
RPRX
| $560K | 0.01% |
268,130
-46,900
| -15% | -$92.8K |
|
|
STML
698
DELISTED
Stemline Therapeutics, Inc.
STML
| $555K | 0.01% |
51,243
-4,611
| -8% | -$37.5K |
|
699
CSX Corp
CSX
$98.6B
| $544K | 0.01% |
53,550
-2,580
| -5% | -$24.4K |
|
|
GIFI
700
DELISTED
Gulf Island Fabrication
GIFI
| $540K | 0.01% |
58,733
-9,200
| -14% | -$76.2K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.